# Teva Parenteral Medicines, Inc., Irvine, CA – FDA Inspections Source: https://www.keypedia.com/companies/teva-parenteral-medicines-inc/0fca6486-3040-4806-b72d-ff1c31d675c1 > Inspection records and compliance data for Teva Parenteral Medicines, Inc. in Irvine, California. 12 FDA inspections on record (2 OAI), 2 Form 483s, last inspected August 20, 2021. --- ## Details - Name: Teva Parenteral Medicines, Inc. - FEI Number: 2027158 - Facility Type: Manufacturer - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK - Address Line 1: 19 Hughes - City: Irvine - State: California - Zip Code: 92618 - Country Name: United States - Address: 19 Hughes, Irvine, California 92618, United States - Country: United States ## Related Documents - [483 - Teva Parenteral Medicines, Inc. - 2021-08-20](https://www.keypedia.com/records/483/teva-parenteral-medicines-inc/b639b463-9013-4135-a37d-81c31801d356) — source: FDA, date: August 20, 2021 - [FDA Inspection 1149378 - Teva Parenteral Medicines, Inc. - 2021-08-20](https://www.keypedia.com/records/fda_inspections/teva-parenteral-medicines-inc/ff5b4440-dec5-48d1-8ee4-005907b133c2) — classification: Official Action Indicated (OAI), source: FDA, date: August 20, 2021 - [EIR - Teva Parenteral Medicines, Inc. - 2019-08-30](https://www.keypedia.com/records/eir/teva-parenteral-medicines-inc/ad108266-c6e7-4990-9ec5-b8066d2cace1) — source: FDA, date: August 30, 2019 - [483 - Teva Parenteral Medicines, Inc. - 2019-08-30](https://www.keypedia.com/records/483/teva-parenteral-medicines-inc/c0bfa6e1-e202-45f2-a51e-ce981832063d) — source: FDA, date: August 30, 2019 - [FDA Inspection 1100853 - Teva Parenteral Medicines, Inc. - 2019-08-30](https://www.keypedia.com/records/fda_inspections/teva-parenteral-medicines-inc/a0419dde-20ca-4421-89a3-71c798a81f81) — classification: No Action Indicated (NAI), source: FDA, date: August 30, 2019 - FDA Inspection 1100853 - Teva Parenteral Medicines, Inc. - 2019-08-30 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 30, 2019 - [483 - Teva Parenteral Medicines, Inc. - 2019-01-18](https://www.keypedia.com/records/483/teva-parenteral-medicines-inc/dc6743ea-2a3e-415d-8ebd-114d581bd7f9) — source: FDA, date: January 18, 2019 - [FDA Inspection 1077528 - Teva Parenteral Medicines, Inc. - 2019-01-18](https://www.keypedia.com/records/fda_inspections/teva-parenteral-medicines-inc/e47fc7f6-00f8-4471-b12c-3986a95c6d45) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 18, 2019 - FDA Inspection 997582 - Teva Parenteral Medicines, Inc. - 2016-12-19 — classification: No Action Indicated (NAI), source: FDA, date: December 19, 2016 - [483 - Teva Parenteral Medicines, Inc. - 2016-07-29](https://www.keypedia.com/records/483/teva-parenteral-medicines-inc/99b91acf-e741-4421-a041-dff87c580e22) — source: FDA, date: July 29, 2016 - FDA Inspection 980903 - Teva Parenteral Medicines, Inc. - 2016-07-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 29, 2016 - [483 - Teva Parenteral Medicines, Inc. - 2015-07-10](https://www.keypedia.com/records/483/teva-parenteral-medicines-inc/497190da-6b42-489c-b17b-7057080cab8a) — source: FDA, date: July 10, 2015 - FDA Inspection 882240 - Teva Parenteral Medicines, Inc. - 2014-06-06 — classification: No Action Indicated (NAI), source: FDA, date: June 6, 2014 - [483 - Teva Parenteral Medicines, Inc. - 2013-06-04](https://www.keypedia.com/records/483/teva-parenteral-medicines-inc/a341f217-c45e-4025-8a02-d53234f20847) — source: FDA, date: June 4, 2013 - [FDA Inspection 834806 - Teva Parenteral Medicines, Inc. - 2013-06-04](https://www.keypedia.com/records/fda_inspections/teva-parenteral-medicines-inc/3d2dc942-c974-44a5-93ac-a292b067dfb8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 4, 2013 - FDA Inspection 794284 - Teva Parenteral Medicines, Inc. - 2012-08-10 — classification: No Action Indicated (NAI), source: FDA, date: August 10, 2012 - [483 - Teva Parenteral Medicines, Inc. - 2012-04-24](https://www.keypedia.com/records/483/teva-parenteral-medicines-inc/f7a6bed1-b9b0-4d1c-9a00-118a6663a935) — source: FDA, date: April 24, 2012 - [EIR - Teva Parenteral Medicines, Inc. - 2012-04-24](https://www.keypedia.com/records/eir/teva-parenteral-medicines-inc/b299d610-ae8c-472a-874f-b86459f675d6) — source: FDA, date: April 24, 2012 - [FDA Inspection 779321 - Teva Parenteral Medicines, Inc. - 2012-04-24](https://www.keypedia.com/records/fda_inspections/teva-parenteral-medicines-inc/cbf10a34-d00d-4548-bb82-13db30750338) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 24, 2012 - [EIR - Teva Parenteral Medicines, Inc. - 2010-05-14](https://www.keypedia.com/records/eir/teva-parenteral-medicines-inc/6a358c56-b202-4ff2-beac-e0b9413decf7) — source: FDA, date: May 14, 2010 ## Related Companies - [Downing Labs, LLC](https://www.keypedia.com/companies/downing-labs-llc/58d772b6-995b-45ec-82ba-17256caa081c) - [Elemental Herbs, Inc.](https://www.keypedia.com/companies/elemental-herbs-inc/890bf933-35cd-471c-91e7-bd340b1d0812) - [Samer K. Khaled, M.D.](https://www.keypedia.com/companies/samer-k-khaled-md/daa94244-9556-4238-a190-7d599a3b496a) - [Ultra Chem Labs Corp](https://www.keypedia.com/companies/ultra-chem-labs-corp/90f42943-ba7c-42bc-b14e-5a1996a77e4c) - [Dante Pieramici, M.D.](https://www.keypedia.com/companies/dante-pieramici-md/2cec9173-4c6c-4419-971c-3e1d6a0c24ea) - [New Look Cosmetics, Inc.](https://www.keypedia.com/companies/new-look-cosmetics-inc/68bc2fb1-35d7-4967-ad21-28ba034acc6e) - [Milton Hom, OD](https://www.keypedia.com/companies/milton-hom-od/18a465e9-c126-4417-9612-16f28c7baa42) - [Ardelyx, Inc.](https://www.keypedia.com/companies/ardelyx-inc/ca34caa9-3440-4e27-a0d0-177a42cc469e) - [Manoj K. Patel](https://www.keypedia.com/companies/manoj-k-patel/c4e2b726-d321-4c40-815a-b307f5f7a8e6) - [Rachel A. Kuperman, M.D.](https://www.keypedia.com/companies/rachel-a-kuperman-md/b5aa5aed-8f9e-4916-95dd-c851ce6fc2df) ## Related Officers - [Caryn Mcnab](https://www.keypedia.com/people/caryn-mcnab/05d5f65d-5ab2-4798-a3a2-2798a82237e1) - [Laboratory Director](https://www.keypedia.com/people/jennifer-m-gogley/2025f306-80a6-4222-89ac-e4138028292a) - [Consumer Safety Officer (Drug Specialist)](https://www.keypedia.com/people/alan-p-kurtzberg/36ee316e-6d19-44b2-a131-fc254ada4f41) - [SVP Consulting & Operations](https://www.keypedia.com/people/linda-f-murphy/a8b9737f-d5f4-4a36-8684-2fb050d008f2) - [company_representative](https://www.keypedia.com/people/paul-smith/240c4178-4d99-411e-8ecc-9ed865e0cd1c) - [company_representative](https://www.keypedia.com/people/manjula-ghosh/26b4f832-70fe-4394-96f9-40be06f334c4)